Search - tctmd.com

Displaying 221 - 240 of 893

Sort: Relevancy | Date

Presentation TCT 2022

Modular Transcatheter Transseptal “ReValvable” Mitral Valve Replacement (ReValve): FIH Results

Presenter: Charles J. Davidson

September 18, 2022

Presentation TCT 2022

Chordal Replacement and Annuloplasty in One Device With a Leaflet-Independent Procedure for DMR (Vesalius)

Presenter: Peter Skarsgard

September 18, 2022

Presentation TCT 2022

Bringing Mitral Technologies to the Right: Key Physiological and Hemodynamic Differences

Presenter: Ajit P. Yoganathan

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

Presentation TCT 2022

TCT 791: Concomitant transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve-in-ring (TMViR) procedure with transfemoral approach

Presenter: Smitha Narayana Gowda

September 17, 2022

Presentation TCT 2022

TCT 617: Mitral leaflet cutting before transcatheter mitral valve replacement - the Mitra-Cut technique.

Presenter: Martin Andreas

September 17, 2022

Presentation TCT 2022

TCT 741: Accurate pre-procedural planning using 3D computational modeling in transcatheter mitral valve replacement in mitral stenosis.

Presenter: Mark Van den Dorpel

September 17, 2022

Presentation TCT 2022

TCT 612: First comconitant double transcatheter valve replacement in native anatomy using dedicated devices

Presenter: Raj Makkar

September 17, 2022

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

Presentation TVT 2022

M3

Presenter: David Daniels

June 10, 2022

Presentation TVT 2022

APOLLO

Presenter: Martin B. Leon

June 10, 2022

Presentation TVT 2022

SUMMIT

Presenter: Gorav Ailawadi

June 10, 2022

Presentation TVT 2022

Residual ASD Post-TMVR: Severity Assessment and Indication for Closure

Presenter: Torsten P. Vahl

June 10, 2022

Presentation TVT 2022

LVOT Obstruction Post-TMVR: Predictors, Prevention, and Post-interventional Management

Presenter: Vinayak N. Bapat

June 10, 2022

Presentation TVT 2022

Patient Selection in TMVR Trials: Where Surgery and Catheter-based Therapies Separate or Overlap

Presenter: Eberhard Grube

June 10, 2022

Presentation TVT 2022

Characterization and management of iatrogenic atrial septal defects after transseptal transcatheter mitral valve replacement with the Sapien 3 valve

Presenter: Lauren Ranard

June 09, 2022

Advertisement

Modular Transcatheter Transseptal “ReValvable” Mitral Valve Replacement (ReValve): FIH Results

Chordal Replacement and Annuloplasty in One Device With a Leaflet-Independent Procedure for DMR (Vesalius)

Bringing Mitral Technologies to the Right: Key Physiological and Hemodynamic Differences

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

TCT 791: Concomitant transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve-in-ring (TMViR) procedure with transfemoral approach

TCT 617: Mitral leaflet cutting before transcatheter mitral valve replacement - the Mitra-Cut technique.

TCT 741: Accurate pre-procedural planning using 3D computational modeling in transcatheter mitral valve replacement in mitral stenosis.

TCT 612: First comconitant double transcatheter valve replacement in native anatomy using dedicated devices

FDA Approves Pascal TEER Device for Degenerative MR

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Minorities, Poorer Patients Missing Out on Structural Heart Care

M3

APOLLO

SUMMIT

Residual ASD Post-TMVR: Severity Assessment and Indication for Closure

LVOT Obstruction Post-TMVR: Predictors, Prevention, and Post-interventional Management

Patient Selection in TMVR Trials: Where Surgery and Catheter-based Therapies Separate or Overlap

Characterization and management of iatrogenic atrial septal defects after transseptal transcatheter mitral valve replacement with the Sapien 3 valve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content